- Fee assured
- Awaiting verification
Dr Jason Lester qualified from Guy's Hospital Medical School, London in 1993 and trained in general medicine in the South East of England. He completed his oncological training in 2003, and was appointed as a Consultant Oncologist at Velindre Cancer Centre the same year.
Areas of interest
Non-surgical treatment of lung cancer, mesothelioma and urological cancers (prostate, kidney and bladder cancer);
Chemotherapy and targeted therapy for lung and urological cancers; Stereotactic radiotherapy for early lung cancer; Combined modality therapy for locally advanced lung cancer; Brachytherapy for prostate cancer; IMRT / IGRT radiotherapy for prostate cancer; Bladder sparing treatment for bladder cancer
Current NHS consultant posts held
Consultant Clinical Oncologist Velindre Cancer Centre, Cardiff, UK
Associate Clinical Director, Velindre Cancer Centre
Clinical Research Fellow, Cardiff University
Radiotherapy dose escalation in locally advanced non-small cell lung cancer: Chief investigator for the I-START trial
Vaccine therapy for malignant pleural mesothelioma: Chief investigator for the SKOPOS trial
The effect of radiotherapy on Implantable cardiac devices
Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma. Lung cancer 2012
Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement. Clin Oncol. 2009 May;21(4):343-60.
Courses offered to GPs
I give regular talks to local and regional GPs on any aspect of lung cancer and urological cancer management. Please contact my secretary for further information.
- Bachelor of Medicine, Bachelor of Surgery London 1993
- Member of the Royal College of Physicians Royal College of physicians 1997
- Fellow of the Royal College of Radiologists Royal College of Radiologists 2001
Professional bodies (positions held - last 3 yrs)
- Committee member British Thoracic Oncology Steering Group 2011
- Committee member NCRI lung cancer advanced disease subgroup 2011
Details of entry to specialist register
- Clinical Oncology, 2003
Affiliations / memberships
British Thoracic Oncology Group
- Velindre Hospital
- 16:00 - 19:30
- 029 2019 6159
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
The patient should contact me unless instructed otherwise.